ClinicalTrials.gg
RecruitingNCT03907046ASPIREUpdated May 8, 2026

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

A Phase 3 interventional study of Apixaban and Aspirin in Intracerebral Hemorrhage and Atrial Fibrillation, sponsored by Yale University. Recruiting at 187 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by Yale University · Phase 3, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Jan 2020; still recruiting 6 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
700
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 109 studies in Cerebral Hemorrhage with a site in United States — 31 open to participants now, 42 under way, 6 of them phase 3. Cerebral Hemorrhage · United States.

Planned enrollment
9th of 71
700 · median 60
Started
2020
with 8 others
Phase 3
8 of 109
3 open now
Primary completion
2027-04
later than 15 of 41 live
Registered
59th of 109
by date

Among the 109 studies in Cerebral Hemorrhage with a site in United States, this one is the 9th largest by planned enrollment of the 71 interventional ones that give a count, is one of 9 that started in 2020, is one of 8 in phase 3, reaches primary completion later than 15 of the 41 other live ones, and was the 59th registered.

Cerebral Hemorrhage

458 studies on the registry are indexed under Cerebral Hemorrhage; 173 are open to participants now.

Browse Cerebral Hemorrhage studies →

Open to participants now

31 of the 109 studies in Cerebral Hemorrhage with a site in United States are open now. Recruiting first, the newest first:

26 more — sign in →

All 31 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 115 Cerebral Hemorrhage studies recruiting now, 61 (53%) set no upper age limit and 9 (8%) stop at 75 or younger; 4 take children under 18; 6 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 109 studies in Cerebral Hemorrhage with a site in United States, or all of them as a file.
02

Study summary

Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF).

Secondary Aim: To determine if apixaban, compared with aspirin, results in better functional outcomes as measured by the modified Rankin Scale.

Read the detailed description

ASPIRE is a randomized, double-blinded, phase III clinical trial designed to test the efficacy and safety of anticoagulation, compared with aspirin, in patients with a recent ICH and non-valvular AF. Seven hundred patients will be enrolled over 3.5 years and followed for study outcomes for a minimum of 12 months and maximum of 36 months. The primary efficacy outcome is any stroke (hemorrhagic or ischemic) or death from any cause. The secondary efficacy outcome is the change in the modified Rankin Scale score. Recruitment will take place at sites coordinated through the NIH/NINDS StrokeNet.

03

Conditions studied

  • Intracerebral Hemorrhage
  • Atrial Fibrillation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age at least 18 years
  • Intracerebral hemorrhage (ICH) (including primary intraventricular hemorrhage) confirmed by brain CT or MRI
  • Can be randomized within 14-180 days after ICH onset
  • Non-valvular AF (defined as atrial fibrillation or atrial flutter), documented by electrocardiography or a physician-confirmed history of prior AF
  • Provision of signed and dated form by patient or legally authorized representative
  • For females of : use of highly effective

Exclusion criteria

Exclusion Criteria:

  • Index event is hemorrhagic transformation of a brain infarction or hemorrhage into a tumor
  • History of earlier ICH within 12 months preceding index event
  • Active infective endocarditis
  • Clear indication for anticoagulant drugs (e.g., requires anticoagulation for deep vein thrombosis or pulmonary embolism) or antiplatelet drugs (e.g., requires aspirin or clopidogrel for recent coronary stent).
  • Previous or planned left atrial appendage closure
  • bleeding diathesis
  • Serum creatinine ≥2.5 mg/dL
  • Active hepatitis or hepatic insufficiency with score B or C
  • Anemia ( \<8 g/dL) or thrombocytopenia (\<100 x 10\^9/L) that is chronic in the judgment of the investigator
  • Pregnant or breastfeeding
  • Known allergy to aspirin or apixaban
  • Concomitant participation in a competing trial
  • Considered by the investigator to have a condition that precludes safe or active participation in the trial
  • Persistent, uncontrolled systolic blood pressure (≥180 mm Hg)
  • ICH caused by an arteriovenous malformation (AVM) that has not yet been secured
Terms in these criteria, in plain language(6)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Reproductive potential

Able to have children. For women this usually means from the first period until menopause, unless permanently unable to through surgery; for men, unless permanently sterile. Read who the line is about — participants, women, men, or their partners.

Criteria about it usually ask for contraception during the study and for a time after it.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

Child-Pugh class

A score of how well the liver works in people with liver disease such as cirrhosis: class A is mild, B moderate and C severe.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
700 participants (estimated)

Study arms

  • Active comparator
    Apixaban

    Apixaban dosing will be 5 mg tablet in morning and 5 mg tablet in evening. A reduced dose of 2.5 mg tablet in morning and 2.5 mg tablet in evening will be used if: (1) ≥2 of the following are present: age ≥80 years, body weight ≤60 kg, or serum creatinine 1.5-2.4 mg/dL, or (2) Patient is taking a strong CYP3A4/pGP inhibitor (e.g., ketoconazole, itraconazole, ritonavir, or clarithromycin).

    Drug: Apixaban

  • Placebo comparator
    Aspirin

    Aspirin dose will be 81 mg tablet once daily.

    Drug: Aspirin

Interventions

  • Apixaban is an oral anticoagulant of the Factor Xa inhibitor class.

    Also known as: Eliquis

  • DrugAspirin

    Aspirin is an oral antiplatelet drug.

06

What researchers measure

Primary outcomes

  1. Stroke or death

    Incidence of stroke of any type (ischemic or hemorrhagic) or death from any cause

    Time frame: Up to 3 years

Secondary outcomes

  1. Modified Rankin Scale (mRS) score

    Measure of neurologic disability (0=no disability to 6=dead)

    Time frame: Change from baseline to 12 months; change over duration of follow-up

07

Study locations

142 of 187 sites recruiting
  • University of Alabama Hospital
    Birmingham, Alabama 35294, United States
    Recruiting
    • Angela Shapshak, MD · Contact
  • University of South Alabama University Hospital
    Mobile, Alabama 36604, United States
    Recruiting
    • Taha Nisar, MD · Contact
  • Chandler Regional Medical Center
    Chandler, Arizona 85224, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • St. Joseph's Hospital and Medical Center
    Phoenix, Arizona 85013, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Banner University Medical Center
    Tucson, Arizona 85719, United States
    Recruiting
    • Firas Kaddouh, MD · Contact
  • UAMS Medical Center
    Little Rock, Arkansas 77205, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Mercy San Juan Medical Center
    Carmichael, California 95608, United States
    Recruiting
    • Lucian Maidan · Contact
  • Eden Medical Center, Castro Valley
    Castro Valley, California 94546, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Arrowhead Regional Medical Center
    Colton, California 92324, United States
    Recruiting
    • Dan Miulli, MD · Contact
  • Rancho Los Amigos National Rehabilitation Center
    Downey, California 90242, United States
    Suspended

    Not enrolling at this site — choose another above.

  • Kaiser Permanente Fontana Medical Center
    Fontana, California 92335, United States
    Recruiting
    • Vaninder Chhabra · Contact
  • Community Regional Medical Center of Fresno
    Fresno, California 93720, United States
    Recruiting
    • Mellekate Vishwas, MD · Contact
  • St. Jude Medical Center
    Fullerton, California 92835, United States
    Recruiting
    • Ashish Nanda, MD · Contact
  • Long Beach Memorial Medical Center
    Long Beach, California 90806, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Los Alamitos Medical Center
    Los Alamitos, California 90720, United States
    Recruiting
    • Nirav Patel, MD · Contact
  • Kaiser Permanente Los Angeles Medical Center
    Los Angeles, California 90027, United States
    Recruiting
    • Harsimran Brara, MD · Contact
  • Cedars-Sinai Medical Center
    Los Angeles, California 90048, United States
    Recruiting
    • Konrad Schlick, MD · Contact
  • Ronald Reagan UCLA Medical Center
    Los Angeles, California 90095, United States
    Recruiting
    • Latisha Sharma, MD · Contact
  • Doctors Medical Center Modesto, Modesto, CA
    Modesto, California 95350, United States
    Recruiting
    • James Jaffe, MD · Contact
  • Hoag Hospital Newport Beach
    Newport Beach, California 92663, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • UC Irvine Medical Center
    Orange, California 92868, United States
    Recruiting
    • Wengui Yu, MD · Contact
  • Desert Regional Medical Center
    Palm Springs, California 92262, United States
    Recruiting
    • Kevin Attenhofer, MD · Contact
  • Huntington Memorial Hospital
    Pasadena, California 91105, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Kaiser Permanente Redwood City Medical Center, Redwood City, CA
    Redwood City, California 94063, United States
    Recruiting
    • Sheila Chan, MD · Contact
  • UC Davis Medical Center
    Sacramento, California 95817, United States
    Recruiting
    • Kwan Ng, MD · Contact
  • Kaiser Permanente Sacramento Medical Center
    Sacramento, California 95825, United States
    Recruiting
    • Yekaterina Axelrod, MD · Contact
  • San Francisco General Hospital
    San Francisco, California 94110, United States
    Recruiting
    • Claude Hemphill, MD · Contact
  • Santa Barbara Cottage Hospital
    Santa Barbara, California 93105, United States
    Recruiting
    • Brian Walcott, MD · Contact
  • Stanford University Medical Center
    Stanford, California 94304, United States
    Recruiting
    • Chitra Venkat, MD · Contact
  • PIH Health Hospital - Whittier
    Whittier, California 90602, United States
    Recruiting
    • Gautam Ganguly, MD · Contact
  • University of Colorado Hospital
    Aurora, Colorado 80045, United States
    Recruiting
    • Sharon Poisson, MD · Contact
  • St. Mary's Medical Center
    Grand Junction, Colorado 81501, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Danbury Hospital
    Danbury, Connecticut 06810, United States
    Suspended

    Not enrolling at this site — choose another above.

  • Hartford Hospital
    Hartford, Connecticut 06102, United States
    Recruiting
    • Mark Alberts, MD · Contact
  • Yale New Haven Hospital
    New Haven, Connecticut 06511, United States
    Recruiting
    • Guido Falcone, MD · Contact
  • New Hanover Regional Medical Center
    Wilmington, Delaware 28403, United States
    Recruiting
    • James McKinney, MD · Contact
  • MedStar Georgetown University Hospital
    Washington D.C., District of Columbia 20007, United States
    Recruiting
    • Douglas Mayson, MD · Contact
  • MedStar Washington Hospital Center
    Washington D.C., District of Columbia 20010, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • George Washington University Hospital
    Washington D.C., District of Columbia 20037, United States
    Recruiting
    • Fernando Mayor Basto, MD · Contact
  • Morton Plant Hospital
    Clearwater, Florida 33756, United States
    Recruiting
    • Ajay Arora, MD · Contact
  • Broward Health Medical Center
    Fort Lauderdale, Florida 33316, United States
    Recruiting
    • Mehdi Mehdi, MD · Contact
  • UF Health Jacksonville
    Jacksonville, Florida 32209, United States
    Recruiting
    • Kimberly McPhearson, MD · Contact
  • Mayo Clinic
    Jacksonville, Florida 32224, United States
    Terminated

    Not enrolling at this site — choose another above.

  • Jackson Memorial Hospital
    Miami, Florida 33136, United States
    Recruiting
    • Sebastian Koch · Contact
  • Ascension Sacred Heart Pensacola
    Pensacola, Florida 32504, United States
    Recruiting
    • Terry Neill, MD · Contact
  • Cleveland Clinic Tradition Hospital
    Port Saint Lucie, Florida 34987, United States
    Recruiting
    • Marc Babi, MD · Contact
  • Tampa General Hospital
    Tampa, Florida 33606, United States
    Recruiting
    • Swetha Renati, MD · Contact
  • St. Joseph's Hospital
    Tampa, Florida 33607, United States
    Recruiting
    • Abilash Haridas, MD · Contact
  • Grady Memorial Hospital
    Atlanta, Georgia 30303, United States
    Recruiting
    • Daniel Schachter, MD · Contact
  • Emory University Hospital
    Atlanta, Georgia 30322, United States
    Recruiting
    • Fadi Nahab, MD · Contact
  • Augusta University Medical Center
    Augusta, Georgia 30912, United States
    Recruiting
    • Fenwick Nichols, MD · Contact
  • WellStar Kennestone Hospital
    Marietta, Georgia 30060, United States
    Recruiting
    • Christopher Horn, MD · Contact
  • The Queen's Medical Center
    Honolulu, Hawaii 96813, United States
    Recruiting
    • Kazuma Nakagawa, MD · Contact
  • Saint Alphonsus Regional Medical Center - Boise
    Boise, Idaho 83706, United States
    Recruiting
    • Lukas Clark, MD · Contact
  • NCH Hospital, Arlington Heights
    Arlington Heights, Illinois 60005, United States
    Recruiting
    • Mohammad Anadani, MD · Contact
  • Rush University Medical Center
    Chicago, Illinois 60612, United States
    Recruiting
    • Alejandro Vargas, MD · Contact
  • University of Illinois Hospital
    Chicago, Illinois 60612, United States
    Recruiting
    • Ali Alaraj, MD · Contact
  • University of Chicago Medical Center
    Chicago, Illinois 60637, United States
    Recruiting
    • Rachel Mehendale, MD · Contact
  • Evanston Hospital
    Evanston, Illinois 60201, United States
    Recruiting
    • Mohammad Anadani, MD · Contact
  • Loyola University Medical Center
    Maywood, Illinois 60153, United States
    Recruiting
    • Sarkis Morales-Vidal, MD · Contact
  • OSF St. Francis Medical Center
    Peoria, Illinois 61637, United States
    Recruiting
    • Arun Talkad · Contact
  • Javon Bea Hospital - Riverside
    Rockford, Illinois 61114, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • St. John's Hospital
    Springfield, Illinois 62769, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Central DuPage Hospital
    Winfield, Illinois 60190, United States
    Recruiting
    • Dhruvil Pandya, MD · Contact
  • IU Health Methodist Hospital
    Indianapolis, Indiana 46202, United States
    Recruiting
    • Lisa Nobel, MD · Contact
  • University of Iowa Medical Center
    Iowa City, Iowa 52242, United States
    Recruiting
    • Amir Shaban, MD · Contact
  • University of Kansas Hospital
    Kansas City, Kansas 66160, United States
    Recruiting
    • Kyle Carpenter, MD · Contact
  • Baptist Health Lexington
    Lexington, Kentucky 40503, United States
    Recruiting
    • Murali Kolikonda, MD · Contact
  • University of Kentucky Hospital
    Lexington, Kentucky 40536, United States
    Recruiting
    • Suhas Gangadhara, MD · Contact
  • University of Louisville Hospital
    Louisville, Kentucky 40202, United States
    Recruiting
    • Isaac Abecassis, MD · Contact
  • Ochsner Medical Center - Main Campus
    New Orleans, Louisiana 70121, United States
    Recruiting
    • Richard Zweifler · Contact
  • Eastern Maine Medical Center
    Bangor, Maine 04401, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Maine Medical Center
    Portland, Maine 04102, United States
    Recruiting
    • Teresa May, MD · Contact
  • Tufts Medical Center
    Boston, Massachusetts 02111, United States
    Recruiting
    • Emiliya Melkumova, MD · Contact
  • Massachusetts General Hospital
    Boston, Massachusetts 02114, United States
    Recruiting
    • Mariel Kozberg, MD · Contact
  • Boston Medical Center
    Boston, Massachusetts 02118, United States
    Recruiting
    • Steven Feske, MD · Contact
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215, United States
    Recruiting
    • Magdy Selim, MD · Contact
  • Lahey Hospital & Medical Center
    Burlington, Massachusetts 01805, United States
    Recruiting
    • Colin James Culbertson, MD · Contact
  • Baystate Medical Center
    Springfield, Massachusetts 01199, United States
    Recruiting
    • Gottfried Schlaug, MD · Contact
  • UMass Memorial Medical Center
    Worcester, Massachusetts 01655, United States
    Recruiting
    • Majaz Moonis, MD · Contact
  • University of Michigan University Hospital
    Ann Arbor, Michigan 48109, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Henry Ford Hospital
    Detroit, Michigan 48202, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • McLaren Flint
    Flint, Michigan 48532, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Trinity Health Saint Mary's
    Grand Rapids, Michigan 49503, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Trinity Health Saint Mary's
    Grand Rapids, Michigan 49503, United States
    Recruiting
    • Muhammad Farooq, MD · Contact
  • McLaren Macomb
    Mount Clemens, Michigan 48043, United States
    Terminated

    Not enrolling at this site — choose another above.

  • Munson Medical Center
    Traverse City, Michigan 49684, United States
    Recruiting
    • Ramiro Castro-Apolo, MD · Contact
  • Metro Health Hospital
    Wyoming, Michigan 49519, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Abbott Northwestern Hospital
    Minneapolis, Minnesota 55407, United States
    Recruiting
    • Ganesh Asaithambi, MD · Contact
  • M Health Fairview University of Minnesota Medical Center
    Minneapolis, Minnesota 55455, United States
    Recruiting
    • Oladi Bentho, MD · Contact
  • St. Cloud Hospital
    Saint Cloud, Minnesota 56303, United States
    Recruiting
    • Muhammad Fareed Suri, MD · Contact
  • HealthPartners Methodist Hospital
    Saint Louis Park, Minnesota 55426, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Regions Hospital
    Saint Paul, Minnesota 55101, United States
    Terminated

    Not enrolling at this site — choose another above.

  • United Hospital, St. Paul
    Saint Paul, Minnesota 55102, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • University of Mississippi Medical Center
    Jackson, Mississippi 39216, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • University of Missouri Health Care
    Columbia, Missouri 65212, United States
    Recruiting
    • Farhan Siddiq, MD · Contact
  • Mercy Hospital Springfield
    Springfield, Missouri 65804, United States
    Recruiting
    • Brenton Coger, MD · Contact
  • Cox Medical Center South
    Springfield, Missouri 65807, United States
    Recruiting
    • Benjamin Lisle, MD · Contact
  • Barnes Jewish Hospital
    St Louis, Missouri 63110, United States
    Recruiting
    • Yan Wang, MD · Contact
  • Mercy Hospital South
    St Louis, Missouri 63128, United States
    Recruiting
    • Venkat Chintapally-Rao, MD · Contact

Showing the first 100 of 187 sites. Choose a country and city above to see the rest.

08

References and documents

Publications

  • Cochrane A, Chen C, Stephen J, Ronning OM, Anderson CS, Hankey GJ, Al-Shahi Salman R. Antithrombotic treatment after stroke due to intracerebral haemorrhage. Cochrane Database Syst Rev. 2023 Jan 26;1(1):CD012144. doi: 10.1002/14651858.CD012144.pub3. PubMed 36700520 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2020 (actual). Primary completion is estimated for Apr 2027, 87 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 4, 2019
First posted
Apr 8, 2019
StartActual
Jan 28, 2020
Primary completionEst.
Apr 2027
CompletionEst.
Apr 2027
Last update
May 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03907046
Lead sponsor
Yale University
Responsible party
Sponsor
First posted
Apr 8, 2019
Start date
Jan 28, 2020
Primary completion
Apr 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
May 8, 2026

Study contacts

Kevin N Sheth, MD
Contact
kevin.sheth@yale.edu
443-615-4729
Hooman Kamel, MD
Contact
hok9010@med.cornell.edu
646-962-8284
Kevin N Sheth, MD
principal investigator · Yale University
Hooman Kamel, MD
principal investigator · Weill Medical College of Cornell University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Apixaban

Start the discussion